Delavirdine Mesylate

甲磺酸地拉韦定

Report date: 2022/01/21 20:00:34
NME

Base Information

Drug NameDelavirdine Mesylate
Drug Alias Name甲磺酸地拉维定delavirdinum地拉韦定甲磺酸delavirdina帕米膦酸 +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHuman immunodeficiency virus type 1 reverse transcriptase inhibitors
TargetsHuman immunodeficiency virus type 1 reverse transcriptase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsHIV Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1997/04/04
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmacia & UpjohnViiv Healthcare Co
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeJ05AG02
Related LinksWikipediaDrugBankKEGG